Kristine E Ensrud1, Neeta Parimi2, Howard A Fink3, Areef Ishani4, Brent C Taylor3, Michael Steffes5, Jane A Cauley6, Cora E Lewis7, Eric S Orwoll8. 1. Department of Medicine, University of Minnesota, Minneapolis, MN; Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN; Center for Chronic Disease Outcomes Research, VA Health Care System, Minneapolis, MN. Electronic address: ensru001@umn.edu. 2. California Pacific Medical Center Research Institute, San Francisco, CA. 3. Department of Medicine, University of Minnesota, Minneapolis, MN; Division of Epidemiology & Community Health, University of Minnesota, Minneapolis, MN; Center for Chronic Disease Outcomes Research, VA Health Care System, Minneapolis, MN. 4. Department of Medicine, University of Minnesota, Minneapolis, MN; Department of Nephrology, VA Health Care System, Minneapolis, MN. 5. Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN. 6. Department of Epidemiology, University of Pittsburgh, Pittsburgh, PA. 7. Division of Preventative Medicine, University of Alabama, Birmingham, AL. 8. Bone & Mineral Unit, Oregon Health & Science University, Portland, OR.
Abstract
BACKGROUND: Higher serum cystatin C level is associated with an increased risk of hip fracture in postmenopausal white women, but there is a paucity of data for men. Whether estimated glomerular filtration rate (eGFR) based on cystatin C (eGFRcys) is superior in predicting hip fracture risk to eGFR based on creatinine (eGFRcr) or the combination (eGFR(cr-cys)) also is uncertain. STUDY DESIGN: Nested case-cohort. SETTING & PARTICIPANTS: Participants enrolled in the Osteoporotic Fractures in Men (MrOS) Study (5,994 men aged ≥ 65 years from 6 US centers) including a random subcohort of 1,602 men and 168 men with incident hip fractures (51 of whom were in the subcohort). PREDICTOR: eGFR(cys), eGFR(cr), and eGFR(cr-cys) computed using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and expressed in categories of <60, 60-74, and ≥ 75 mL/min/1.73 m(2) (referent group). OUTCOME: Incident hip fracture ascertained by participant contacts every 4 months and confirmed with radiographic reports. RESULTS: Median eGFR(cys) was 72.9 (IQR, 60.5-85.7) mL/min/1.73 m(2). In unadjusted models, all measures of eGFR were associated with increased hip fracture risk. However, after adjustment for age, race, site, and body mass index, the association of lower eGFR(cys) (but not lower eGFR(cr) or lower eGFR(cr-cys)) with higher hip fracture risk remained: for <60 versus ≥ 75 mL/min/1.73 m(2), HRs were 1.96 [95% CI, 1.25-3.09], 0.84 [95% CI, 0.52-1.37], and 1.08 [95% CI, 0.66-1.77] for eGFR(cys), eGFR(cr), and eGFR(cr-cys), respectively. Similarly, after adjustment for age, race, site, and body mass index, eGFR < 60 mL/min/1.73 m(2) defined by eGFR(cys), but not eGFR(cr) or eGFR(cr-cys), was associated with higher hip fracture risk. The association between eGFR(cys) and hip fracture was not explained by levels of calciotropic hormones or inflammatory markers, but the relationship was attenuated and no longer reached significance (for <60 vs ≥ 75 mL/min/1.73 m(2): HR, 1.43; 95% CI, 0.88-2.34) after consideration of additional clinical risk factors and bone mineral density. LIMITATIONS: Findings not generalizable to other populations; residual confounding may exist. CONCLUSIONS: Older community-dwelling men with lower eGFR(cys) have an increased risk of hip fracture that is explained in large part by greater burden of risk factors among men with lower eGFR(cys). In contrast, lower eGFR(cr) or lower eGFR(cr-cys) was not associated with a higher age-adjusted hip fracture risk. Published by Elsevier Inc.
BACKGROUND: Higher serum cystatin C level is associated with an increased risk of hip fracture in postmenopausal white women, but there is a paucity of data for men. Whether estimated glomerular filtration rate (eGFR) based on cystatin C (eGFRcys) is superior in predicting hip fracture risk to eGFR based on creatinine (eGFRcr) or the combination (eGFR(cr-cys)) also is uncertain. STUDY DESIGN: Nested case-cohort. SETTING & PARTICIPANTS: Participants enrolled in the Osteoporotic Fractures in Men (MrOS) Study (5,994 men aged ≥ 65 years from 6 US centers) including a random subcohort of 1,602 men and 168 men with incident hip fractures (51 of whom were in the subcohort). PREDICTOR: eGFR(cys), eGFR(cr), and eGFR(cr-cys) computed using the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equations and expressed in categories of <60, 60-74, and ≥ 75 mL/min/1.73 m(2) (referent group). OUTCOME: Incident hip fracture ascertained by participant contacts every 4 months and confirmed with radiographic reports. RESULTS: Median eGFR(cys) was 72.9 (IQR, 60.5-85.7) mL/min/1.73 m(2). In unadjusted models, all measures of eGFR were associated with increased hip fracture risk. However, after adjustment for age, race, site, and body mass index, the association of lower eGFR(cys) (but not lower eGFR(cr) or lower eGFR(cr-cys)) with higher hip fracture risk remained: for <60 versus ≥ 75 mL/min/1.73 m(2), HRs were 1.96 [95% CI, 1.25-3.09], 0.84 [95% CI, 0.52-1.37], and 1.08 [95% CI, 0.66-1.77] for eGFR(cys), eGFR(cr), and eGFR(cr-cys), respectively. Similarly, after adjustment for age, race, site, and body mass index, eGFR < 60 mL/min/1.73 m(2) defined by eGFR(cys), but not eGFR(cr) or eGFR(cr-cys), was associated with higher hip fracture risk. The association between eGFR(cys) and hip fracture was not explained by levels of calciotropic hormones or inflammatory markers, but the relationship was attenuated and no longer reached significance (for <60 vs ≥ 75 mL/min/1.73 m(2): HR, 1.43; 95% CI, 0.88-2.34) after consideration of additional clinical risk factors and bone mineral density. LIMITATIONS: Findings not generalizable to other populations; residual confounding may exist. CONCLUSIONS: Older community-dwelling men with lower eGFR(cys) have an increased risk of hip fracture that is explained in large part by greater burden of risk factors among men with lower eGFR(cys). In contrast, lower eGFR(cr) or lower eGFR(cr-cys) was not associated with a higher age-adjusted hip fracture risk. Published by Elsevier Inc.
Entities:
Keywords:
Kidney function; creatinine; cystatin C; elderly; hip fracture; men
Authors: Christine G Lee; Edward J Boyko; Carrie M Nielson; Marcia L Stefanick; Douglas C Bauer; Andrew R Hoffman; Thuy-Tien L Dam; Jodi A Lapidus; Peggy Mannen Cawthon; Kristine E Ensrud; Eric S Orwoll Journal: J Am Geriatr Soc Date: 2011-02-02 Impact factor: 5.562
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Lesley A Inker; John Eckfeldt; Andrew S Levey; Catherine Leiendecker-Foster; Gregory Rynders; Jane Manzi; Salman Waheed; Josef Coresh Journal: Am J Kidney Dis Date: 2011-08-19 Impact factor: 8.860
Authors: Lesley A Inker; Christopher H Schmid; Hocine Tighiouart; John H Eckfeldt; Harold I Feldman; Tom Greene; John W Kusek; Jane Manzi; Frederick Van Lente; Yaping Lucy Zhang; Josef Coresh; Andrew S Levey Journal: N Engl J Med Date: 2012-07-05 Impact factor: 91.245
Authors: Michael G Shlipak; Linda F Fried; Casey Crump; Anthony J Bleyer; Teri A Manolio; Russell P Tracy; Curt D Furberg; Bruce M Psaty Journal: Circulation Date: 2003-01-07 Impact factor: 29.690
Authors: Kristine E Ensrud; Neeta Parimi; Jane A Cauley; Areef Ishani; Yelena Slinin; Teresa A Hillier; Brent C Taylor; Michael Steffes; Steven R Cummings Journal: J Bone Miner Res Date: 2013-06 Impact factor: 6.741
Authors: Tamara Isakova; Timothy E Craven; Julia J Scialla; Thomas L Nickolas; Adrian Schnall; Joshua Barzilay; Ann V Schwartz Journal: Bone Date: 2015-04-30 Impact factor: 4.398
Authors: Howard A Fink; Tien N Vo; Lisa Langsetmo; Joshua I Barzilay; Jane A Cauley; John T Schousboe; Eric S Orwoll; Muna T Canales; Areef Ishani; Nancy E Lane; Kristine E Ensrud Journal: J Bone Miner Res Date: 2017-02-21 Impact factor: 6.741
Authors: Kristen L Nowak; Kristine Yaffe; Eric S Orwoll; Joachim H Ix; Zhiying You; Elizabeth Barrett-Connor; Andrew R Hoffman; Michel Chonchol Journal: Clin J Am Soc Nephrol Date: 2018-02-08 Impact factor: 8.237
Authors: Michelle R Denburg; Juhi Kumar; Thomas Jemielita; Ellen R Brooks; Amy Skversky; Anthony A Portale; Isidro B Salusky; Bradley A Warady; Susan L Furth; Mary B Leonard Journal: J Am Soc Nephrol Date: 2015-07-02 Impact factor: 10.121
Authors: Natalie Daya; Annie Voskertchian; Andrea L C Schneider; Shoshana Ballew; Mara McAdams DeMarco; Josef Coresh; Lawrence J Appel; Elizabeth Selvin; Morgan E Grams Journal: Am J Kidney Dis Date: 2015-08-04 Impact factor: 8.860